AppliedVR Inc.
Developer of evidence-based immersive therapeutics delivering prescription, at-home virtual reality (VR) programs for treatment of chronic pain and anxiety. The company emphasizes clinical validation (randomized controlled trials and real-world outcomes), regulatory authorization for prescription-use VR therapeutics, academic and clinical partnerships, and payer-focused market access programs for distribution to patients in home and institutional settings.
Industries
N/A
Nr. of Employees
small (1-50)
AppliedVR Inc.
Patents
Products
RelieVRx
A prescription-use, in-home immersive virtual reality therapeutic system delivering an eight-week, sequential behavioral skills program intended as adjunctive treatment for chronic lower back pain in adults.
RelieVRx
A prescription-use, in-home immersive virtual reality therapeutic system delivering an eight-week, sequential behavioral skills program intended as adjunctive treatment for chronic lower back pain in adults.
Services
Partnerships to design and execute clinical studies evaluating immersive therapeutic interventions for pain and anxiety.
Development of evidence-based programs for payers and workers' compensation stakeholders to deploy at-home immersive therapeutics for claimants.
Partnership development, market access strategy, and commercial distribution planning for prescription immersive therapeutics.
Partnerships to design and execute clinical studies evaluating immersive therapeutic interventions for pain and anxiety.
Development of evidence-based programs for payers and workers' compensation stakeholders to deploy at-home immersive therapeutics for claimants.
Partnership development, market access strategy, and commercial distribution planning for prescription immersive therapeutics.
Expertise Areas
- Clinical trial management and remote RCTs
- Prescription digital therapeutics for chronic pain
- Behavioral intervention development (CBT-informed)
- Regulatory strategy and reimbursement coding
Key Technologies
- Immersive virtual reality (VR)
- Extended reality (XR) therapeutics
- Gaze-based hands-free interaction
- Digital therapeutics software platform
News & Updates
Announcement that a HCPCS Level II code was obtained for a VR therapeutic listed as durable medical equipment.
Release of outcomes data from a large clinical trial evaluating home-based VR treatment for chronic low back pain.
Clinical results published in collaboration with a neurotechnology partner assessing brain changes associated with VR treatment for chronic pain.
Announcement of a contract award to provide VR therapeutic services through a VA innovation program.
Randomized controlled pilot study evaluating feasibility, acceptability, and preliminary efficacy of a self-administered VR behavioral program compared with an audio-only control.
Regulatory authorization of an at-home prescription immersive VR therapeutic for adjunctive treatment of chronic lower back pain.
Announcement that a HCPCS Level II code was obtained for a VR therapeutic listed as durable medical equipment.
Release of outcomes data from a large clinical trial evaluating home-based VR treatment for chronic low back pain.
Clinical results published in collaboration with a neurotechnology partner assessing brain changes associated with VR treatment for chronic pain.
Announcement of a contract award to provide VR therapeutic services through a VA innovation program.
Randomized controlled pilot study evaluating feasibility, acceptability, and preliminary efficacy of a self-administered VR behavioral program compared with an audio-only control.
Regulatory authorization of an at-home prescription immersive VR therapeutic for adjunctive treatment of chronic lower back pain.